Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Muse cells keep their special features and can become different cell types even after being frozen and thawed three times.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Removing senescent cells can improve hair growth and regeneration.

Researchers made new compounds that could potentially be developed into anticancer drugs.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

The drug combination was safe and showed promise in treating advanced tumors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Potential new drugs for treating PCOS were identified.

A new compound was effective for imaging prostate cancer in rats.

These supernatants may help reduce hair loss by protecting hair cells.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Better supportive care is needed to manage chemotherapy side effects.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.